238 related articles for article (PubMed ID: 29427111)
1. Towards the Identification of Molecular Biomarkers of Spinocerebellar Ataxia Type 3 (SCA3)/Machado-Joseph Disease (MJD).
Lima M; Raposo M
Adv Exp Med Biol; 2018; 1049():309-319. PubMed ID: 29427111
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of Mitochondrial DNA Common Deletion Since The Preataxic Stage of Machado-Joseph Disease.
Raposo M; Ramos A; Santos C; Kazachkova N; Teixeira B; Bettencourt C; Lima M
Mol Neurobiol; 2019 Jan; 56(1):119-124. PubMed ID: 29679261
[TBL] [Abstract][Full Text] [Related]
3. Planning Future Clinical Trials for Machado-Joseph Disease.
Saute JAM; Jardim LB
Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
[TBL] [Abstract][Full Text] [Related]
4. Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies.
Chen YS; Hong ZX; Lin SZ; Harn HJ
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357546
[TBL] [Abstract][Full Text] [Related]
5. Selection of Reference Genes for Normalization of Gene Expression Data in Blood of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3 (MJD/SCA3) Subjects.
Ferreira AF; Raposo M; Vasconcelos J; Costa MDC; Lima M
J Mol Neurosci; 2019 Nov; 69(3):450-455. PubMed ID: 31286408
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
de Assis AM; Saute JAM; Longoni A; Haas CB; Torrez VR; Brochier AW; Souza GN; Furtado GV; Gheno TC; Russo A; Monte TL; Castilhos RM; Schumacher-Schuh A; D'Avila R; Donis KC; de Mello Rieder CR; Souza DO; Camey S; Leotti VB; Jardim LB; Portela LV
Front Neurol; 2017; 8():485. PubMed ID: 28979235
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA profiling in the serums of SCA3/MJD patients.
Shi Y; Huang F; Tang B; Li J; Wang J; Shen L; Xia K; Jiang H
Int J Neurosci; 2014 Feb; 124(2):97-101. PubMed ID: 23879331
[TBL] [Abstract][Full Text] [Related]
8. Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease.
Yu YC; Kuo CL; Cheng WL; Liu CS; Hsieh M
J Neurosci Res; 2009 Jun; 87(8):1884-91. PubMed ID: 19185026
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Therapies for Machado-Joseph Disease.
Duarte-Silva S; Maciel P
Adv Exp Med Biol; 2018; 1049():369-394. PubMed ID: 29427114
[TBL] [Abstract][Full Text] [Related]
10. Profiling of mitochondrial genomes in SCA3/MJD patients from mainland China.
Yuan H; Yang H; Peng L; Peng Y; Chen Z; Wan L; Wang C; Shi Y; Zhang VW; Tang B; Qiu R; Jiang H
Gene; 2020 May; 738():144487. PubMed ID: 32087274
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA haplogroups and age at onset of Machado-Joseph disease/spinocerebellar ataxia type 3: a study in patients from multiple populations.
Ramos A; Planchat M; Vieira Melo AR; Raposo M; Shamim U; Suroliya V; Srivastava AK; Faruq M; Morino H; Ohsawa R; Kawakami H; Bannach Jardim L; Saraiva-Pereira ML; Vasconcelos J; Santos C; Lima M
Eur J Neurol; 2019 Mar; 26(3):506-512. PubMed ID: 30414314
[TBL] [Abstract][Full Text] [Related]
12. Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3.
Siebert M; Donis KC; Socal M; Rieder CR; Emmel VE; Vairo F; Michelin-Tirelli K; França M; D'Abreu AC; Bettencourt C; Lima M; Lopes Cendes I; Saraiva-Pereira ML; Jardim LB
Parkinsonism Relat Disord; 2012 Feb; 18(2):185-90. PubMed ID: 22001711
[TBL] [Abstract][Full Text] [Related]
13. Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3.
Raposo M; Hübener-Schmid J; Ferreira AF; Vieira Melo AR; Vasconcelos J; Pires P; Kay T; Garcia-Moreno H; Giunti P; Santana MM; Pereira de Almeida L; Infante J; van de Warrenburg BP; de Vries JJ; Faber J; Klockgether T; Casadei N; Admard J; Schöls L; ; Riess O; Lima M
Brain; 2023 Oct; 146(10):4132-4143. PubMed ID: 37071051
[TBL] [Abstract][Full Text] [Related]
14. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.
Wilke C; Haas E; Reetz K; Faber J; Garcia-Moreno H; Santana MM; van de Warrenburg B; Hengel H; Lima M; Filla A; Durr A; Melegh B; Masciullo M; Infante J; Giunti P; Neumann M; de Vries J; Pereira de Almeida L; Rakowicz M; Jacobi H; Schüle R; Kaeser SA; Kuhle J; Klockgether T; Schöls L; ; Barro C; Hübener-Schmid J; Synofzik M
EMBO Mol Med; 2020 Jul; 12(7):e11803. PubMed ID: 32510847
[TBL] [Abstract][Full Text] [Related]
15. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
Paulson HL
Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
[TBL] [Abstract][Full Text] [Related]
17. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
Saute JA; Rieder CR; Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; Souza DO; Saraiva-Pereira ML; Portela LV; Camey S; Torman VB; Jardim LB
J Neurol Sci; 2015 Nov; 358(1-2):72-6. PubMed ID: 26297649
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.
Toonen LJA; Overzier M; Evers MM; Leon LG; van der Zeeuw SAJ; Mei H; Kielbasa SM; Goeman JJ; Hettne KM; Magnusson OT; Poirel M; Seyer A; 't Hoen PAC; van Roon-Mom WMC
Mol Neurodegener; 2018 Jun; 13(1):31. PubMed ID: 29929540
[TBL] [Abstract][Full Text] [Related]
19. Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease.
Nakata Y; Sakamoto A; Kawata A
Neuroradiology; 2020 Nov; 62(11):1433-1439. PubMed ID: 32556403
[TBL] [Abstract][Full Text] [Related]
20. The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research.
Lima M; Raposo M; Ferreira A; Melo ARV; Pavão S; Medeiros F; Teves L; Gonzalez C; Lemos J; Pires P; Lopes P; Valverde D; Gonzalez J; Kay T; Vasconcelos J
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
